January 17th, local time, after the Brazilian National Health Supervision Authority officially granted the emergency use license for the Kelapho coronavirus vaccine developed by China Kexing Company, Monica Karasans
A resident of São Paulo, injected the first dose of Kelaphoe coronavirus vaccine at the Affiliated Hospital of the University of São Paulo Medical College, becoming a vaccine in addition to participating in the vaccine trial. In addition to volunteers, Brazil’s first coronavirus vaccinator was injected against Kläräf.
Carassance, 54, is a nurse in the intensive care unit of the Emilio Ribas Institute of Infectious Diseases in São Paulo, one of the medical institutions specializing in treating patients with COVID-19 in and around São Paulo.
Karasans is obese and suffers from both high blood pressure and diabetes. He is at high risk of COVID-19. Since May 2020, Karasans has volunteered to treat COVID-19 patients in the intensive care unit on the front line of the fight against COVID-19.
She also volunteered to participate in the third phase of the Kelifol coronavirus vaccine trial in Brazil, in which she was injected with placebo.
Governor João Doria announced at a press conference on the afternoon of the 17th that the state of São Paulo will launch an emergency vaccination program on January 18 local time.
